Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matthew Kaplan's Stock Ratings
Ladenburg Thalmann Analyst
Matthew Kaplan is an analyst at Ladenburg Thalmann. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/02/2025
Overall Average Return
9.94%
Smart Score
Overall Average Return Percentile
64th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/18/2024 | EYEN | Buy Now | Eyenovia | $1.13 | — | Matthew Kaplan61% | — | Downgrade | Buy → Neutral | Get Alert |
| 10/31/2024 | UTHR | Buy Now | United Therapeutics | $293.85 | 17.07% | Matthew Kaplan61% | $319 → $344 | Maintains | Buy | Get Alert |
| 06/14/2024 | URGN | Buy Now | UroGen Pharma | $11.67 | 358.44% | Matthew Kaplan61% | $48 → $53.5 | Maintains | Buy | Get Alert |
| 05/02/2024 | TGTX | Buy Now | TG Therapeutics | $45.27 | -11.64% | Matthew Kaplan61% | $39 → $40 | Maintains | Buy | Get Alert |
| 04/18/2024 | TGTX | Buy Now | TG Therapeutics | $45.27 | -13.85% | Matthew Kaplan61% | → $39 | Reiterates | Buy → Buy | Get Alert |
| 12/21/2023 | LQDA | Buy Now | Liquidia | $13.93 | 115.36% | Matthew Kaplan61% | $15 → $30 | Maintains | Buy | Get Alert |
| 08/03/2023 | ARDX | Buy Now | Ardelyx | $4.47 | 90.16% | Matthew Kaplan61% | $7.5 → $8.5 | Maintains | Buy | Get Alert |
| 08/03/2023 | UTHR | Buy Now | United Therapeutics | $293.85 | -8.8% | Matthew Kaplan61% | $256 → $268 | Maintains | Buy | Get Alert |
| 07/31/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Matthew Kaplan61% | $122 → $172.5 | Downgrade | Buy → Neutral | Get Alert |
| 06/29/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Matthew Kaplan61% | $104 → $122 | Maintains | Buy | Get Alert |
| 05/04/2023 | UTHR | Buy Now | United Therapeutics | $293.85 | -12.88% | Matthew Kaplan61% | $285 → $256 | Maintains | Buy | Get Alert |
| 05/02/2023 | AVDL | Buy Now | Avadel Pharmaceuticals | $8.98 | 78.12% | Matthew Kaplan61% | $14.5 → $16 | Maintains | Buy | Get Alert |
| 05/02/2023 | TGTX | Buy Now | TG Therapeutics | $45.27 | -17.16% | Matthew Kaplan61% | $26 → $37.5 | Maintains | Buy | Get Alert |
| 03/21/2023 | ATNX | Buy Now | Athenex | — | — | Matthew Kaplan61% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/08/2023 | KPRX | Buy Now | Kiora Pharmaceuticals | $3.24 | 3572.84% | Matthew Kaplan61% | → $1071 | Reiterates | → Buy | Get Alert |
| 08/25/2022 | KPRX | Buy Now | Kiora Pharmaceuticals | $3.24 | 100.62% | Matthew Kaplan61% | → $2340 | Initiates | → Buy | Get Alert |
| 07/22/2022 | LQDA | Buy Now | Liquidia | $13.93 | 7.68% | Matthew Kaplan61% | → $15 | Initiates | → Buy | Get Alert |
| 06/29/2022 | XAIR | Buy Now | Beyond Air | $0.21 | 10749.06% | Matthew Kaplan61% | $17 → $23 | Maintains | Buy | Get Alert |
| 04/14/2022 | ATRS | Buy Now | Antares Pharma | — | — | Matthew Kaplan61% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/21/2022 | ALNA | Buy Now | Allena Pharmaceuticals | — | — | Matthew Kaplan61% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/25/2022 | UTHR | Buy Now | United Therapeutics | $293.85 | -30.92% | Matthew Kaplan61% | $231 → $203 | Maintains | Buy | Get Alert |
| 12/01/2021 | ARDX | Buy Now | Ardelyx | $4.47 | 34.23% | Matthew Kaplan61% | → $6 | Upgrade | Neutral → Buy | Get Alert |
| 11/22/2021 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | Matthew Kaplan61% | → $450 | Initiates | → Buy | Get Alert |
| 10/14/2021 | ARDX | Buy Now | Ardelyx | $4.47 | — | Matthew Kaplan61% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/06/2021 | MLND | Buy Now | Millendo Therapeutics | — | — | Matthew Kaplan61% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/10/2020 | LPCN | Buy Now | Lipocine | $3.23 | -7.12% | Matthew Kaplan61% | → $51 | Upgrade | Neutral → Buy | Get Alert |
| 10/14/2020 | COGT | Buy Now | Cogent Biosciences | $5.63 | -28.95% | Matthew Kaplan61% | → $16 | Initiates | → Buy | Get Alert |
| 01/22/2020 | TARA | Buy Now | Protara Therapeutics | $3.49 | 1189.95% | Matthew Kaplan61% | → $45 | Initiates | → Buy | Get Alert |
| 08/01/2019 | UTHR | Buy Now | United Therapeutics | $293.85 | -63.93% | Matthew Kaplan61% | $103 → $106 | Upgrade | Neutral → Buy | Get Alert |
| 10/25/2018 | ATNX | Buy Now | Athenex | — | — | Matthew Kaplan61% | → $540 | Initiates | → Buy | Get Alert |
| 08/02/2018 | ALNA | Buy Now | Allena Pharmaceuticals | — | — | Matthew Kaplan61% | → $23 | Initiates | → Buy | Get Alert |
| 01/12/2018 | ARDM | Buy Now | Aradigm | — | — | Matthew Kaplan61% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/13/2017 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Matthew Kaplan61% | → $55 | Initiates | → Buy | Get Alert |
| 02/16/2017 | ALBO | Buy Now | Albireo Pharma | — | — | Matthew Kaplan61% | → $40 | Initiates | → Buy | Get Alert |
| 10/28/2016 | UTHR | Buy Now | United Therapeutics | $293.85 | — | Matthew Kaplan61% | — | Upgrade | Neutral → Buy | Get Alert |
| 04/29/2016 | UTHR | Buy Now | United Therapeutics | $293.85 | — | Matthew Kaplan61% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/31/2016 | ARDX | Buy Now | Ardelyx | $4.47 | 369.8% | Matthew Kaplan61% | → $21 | Initiates | → Buy | Get Alert |
| 12/23/2013 | UTHR | Buy Now | United Therapeutics | $293.85 | -53.04% | Matthew Kaplan61% | → $138 | Upgrade | Neutral → Buy | Get Alert |
| 04/30/2012 | UTHR | Buy Now | United Therapeutics | $293.85 | -80.26% | Matthew Kaplan61% | $61 → $58 | Maintains | Buy | Get Alert |
